Oxra-S 10/100 Mg (Dapagliflozin/Sitagliptin)
| Active Ingredient | Dapagliflozin/Sitagliptin |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Sun Pharmaceutical Industries Ltd |
| Strength | 10mg/100mg |
| Packaging | 15 Tablets in 1 strip |
| Delivery Time | 6 To 15 days |
Oxra-S 10/100 mg is a potent oral antidiabetic medication combining Dapagliflozin (10 mg) and Sitagliptin (100 mg), specifically formulated to treat type 2 diabetes mellitus. Dapagliflozin, an SGLT2 inhibitor, works by helping the kidneys eliminate excess glucose through urine. Sitagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces the liver’s glucose production. This powerful dual-action approach improves blood sugar control, especially in patients who struggle to manage their condition with single-drug therapy.
Taken once daily, Oxra-S 10/100 mg can help reduce the risk of long-term diabetes complications. It is well tolerated and typically does not cause weight gain or hypoglycemia. For best results, use this medicine alongside a balanced diet, regular exercise, and ongoing blood sugar monitoring as advised by your doctor.








There are no reviews yet.